Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 3—March 2012
Letter

Carbapenemase-producing Acinetobacter spp. in Cattle, France

Laurent PoirelComments to Author , Béatrice Berçot, Yves Millemann, Rémy A. Bonnin, Glenn Pannaux, and Patrice Nordmann
Author affiliations: Hôpital de Bicêtre, Le Kremlin-Bicêtre, France (L. Poirel, B. Berçot, R.A. Bonnin, P. Nordmann); Hôpital Lariboisière, Paris, France (B. Berçot); Université Paris-Est, Maisons-Alfort, France (Y. Millemann, G. Pannaux)

Main Article

Table

Antimicrobial drug MICs for Acinetobacter genomospecies 15TU isolates from cows and reference strains, France, August 2010

Drug class MIC, μg/mL
Acinetobacter genomospecies 15TU

Reference strain
BY1 BY2–BY9 NIPH 2171 NIPH 899
Penicillins and combinations
Amoxicillin >256 128–256 4 4
Amoxicillin + CLA >256 128–256 4 4
Cephalosporins
Cefoxitin 32 16–32 16 16
Cefotaxime 32 16–32 8 6
Ceftazidime 32 16–32 16 16
Cefepime 16 4–16 4 4
Monobactam (aztreonam) 64 32 32 16
Carbapenems
Meropenem 16 2–4 0.5 0.5
Imipenem >32 4–6 0.25 0.25
Doripenem 8 2–4 0.5 0.5
Cyclines
Tetracycline >256 >256 0.5 0.5
Tigecycline 0.064 0.047–0.064 0.047 0.125
Quinolones (ciprofloxacin) 0.5 0.5 0.25 0.25
Aminoglycosides
Gentamicin 0.5 0.25–0.5 0.25 0.25
Kanamycin >256 >256 0.5 0.5
Sulfonamides 4 4 4 >256

*CLA, clavulanic acid (4 μg/mL).

Main Article

Page created: February 07, 2012
Page updated: February 15, 2012
Page reviewed: February 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external